Regulatory T cells and the eye

Chemical Immunology and Allergy

Volumn 92, Issue , 2007, Pages 131-139

  Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; CHEMOKINE; CYTOKINE; FAS LIGAND; MACROPHAGE MIGRATION INHIBITION FACTOR; RETINA ANTIGEN; SOMATOSTATIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNITY; DELAYED HYPERSENSITIVITY; DOWN REGULATION; EYE INFLAMMATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA; TISSUE REGENERATION; ANIMAL; EYE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; AQUEOUS HUMOR; EYE; HUMANS; IMMUNE TOLERANCE; PIGMENT EPITHELIUM OF EYE; T-LYMPHOCYTES, REGULATORY;

EID: 33947525524     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000099263     Document Type: Article

References (51)

1. Niederkorn J: Immune privilege of the eye; in Chan LS (ed): Animal Models of Human Inflammatory Skin Diseases. New York, CRC Press, 2004, p 564.
2. Niederkorn JY: Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 2002;22:13-46.
3. Niederkorn JY: Immunology and immunomodulation of corneal transplantation. Int Rev Immunol 2002;21:173-196.
4. Niederkorn JY: The immune privilege of corneal grafts. J Leukoc Biol 2003;74:167-171.
5. Streilein JW: OculaT immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3:879-889.
6. Streilein JW: Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 1993;5:428-432.
7. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ: Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 1993;34: 3579-3584.
8. Goslings WR, Prodeus AP, Streilein JW, et al: A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci 1998;39:989-995.
9. Lass JH, Walter EI, Burris TE, et al: Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 1990;31: 1136-1148.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
11. Ciccone E, Pende D, Vitale M, et al: Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol 1994;24:1003-1006.
12. Ljunggren HG, Karre K: In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
13. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED: Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003;64:1039-1044.
14. Niederkorn JY, Chiang EY, Ungchusri T, Stroynowski I: Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 1999;68:1790-1799.
15. CArosella ED, Moreau P, Aractingi S, Rouas-Freiss N: HLA-G: a shield against inflammatory aggression. Trends Immunol 2001;22:553-555.
16. Yoshida M, Kezuka T, Streilein JW: Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest Ophthalmol Vis Sci 2000;41:3862-3870.
17. Taylor AW, Yee DG: Somatostatin is an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 2003;44:2644-2649.
18. Gregerson DS, Dou C: Spontaneous induction of immunoregulation by an endogenous retinal antigen. Invest Ophthalmol Vis Sci 2002;43:2984-2991.
19. Kezuka T, Streilein JW: Analysis of in vivo regulatory properties of T cells activated in vitro by TGFβ-treated antigen presenting cells. Invest Ophthalmol Vis Sci 2000;41:1410-1421.TGF
20. Wilbanks GA, Streilein JW: Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of tw o functionally and phenotypically distinct T-suppressor cell populations. Immunology 1990;71:383-389.
21. Hara Y, Okamoto S, Rouse B, Streilein JW: Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J Immunol 1993;151:5162-5171.
22. D'Orazio TJ, Niederkorn JY: Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998;95:47-55.
23. Niederkorn JY, Mayhew E: Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur J Immunol 1995;25:2783-2787.
24. Skelsey ME, Mayhew E, Niederkorn JY: Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 2003;44:5242-5251.
25. Skelsey ME, Mellon J, Niederkorn JY: Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001;166:4327-4333.
26. Xu Y, Kapp JA: Gamma delta T cells are critical for the induction of anterior chamber-associated immune deviation. Immunology 2001;104:142-148.
27. Faunce DE, Stein-Streilein J: NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002;169:31-38.
28. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J: CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999;190:1215-1226.
29. Wang Y, Goldschneider I, Foss D, et al: Direct thymic involvement in anterior chamber-associated immune deviation: Evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 1997;158:2150-2155.
30. Skelsey ME, Mayhew E, Niederkorn JY: CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003;110:18-29.
31. Li XY, D'Orazio LT, Niederkorn JY: Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 1996;89:34-40.
32. Kosiewicz MM, Streilein JW: Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells. J Immunol 1996;157:1905-1912.
33. Shevach EM: CD4+ CD25+ suMpressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
34. Maloy KJ, Powrie F: Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2: 816-822.
35. Maloy KJ, Salaun L, Cahill R, et al: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-119.
36. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155: 1151-1164.
37. Yu P, Lee Y, Liu W, et al: Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 2005;201:779-791.
38. Nakamura T, Sonoda KH, Faunce DE, et al: CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 2003;171:1266-1271.
39. Nakamura T, Terajewicz A, Stein-Streilein J: Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or ST AT6. J Immunol 2005;175:2643-2646.
40. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
41. HAri S, Sakaguchi S: Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 2004;6:745-751.
42. Helbig H, Gurley RC, Palestine AG, Nussenblatt RB, Caspi RR: Dual effect of ciliary body cells on T lymphocyte proliferation. Eur J Immunol 1990;20:2457-2463.
43. Hooper P, Bora NS, Kaplan HJ, Ferguson TA: Inhibition of lymphocyte proliferation by resident ocular cells. Curr Eye Res 1991;10:363-372.
44. Knisely TL, Bleicher PA, Vibbard CA, Granstein RD: Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr Eye Res 1991;10:761-771.
45. Streilein JW, Bradley D: Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest Ophthalmol Vis Sci 1991;32:2700-2710.
46. Yoshida M, Takeuchi M, Streilein JW: Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest Ophthalmol Vis Sci 2000;41:811-821.
47. Taylor AW: Ocular immunosuppressive microenvironment; in Streilein JW (ed): Immune Response and the Eye. Chem Immunol. Basel, Karger, 1999, vol 73, pp 72-89.
48. Namba K, Kitaichi N, Nishida T, Taylor AW: Induction of regulatory T cells by the immunomodulating cytokines α-melanocyte-stimulating hormone and transforming growth-β2. J Leukoc Biol 2002;72:946-952.
49. Nishida T, Taylor AW: Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci 1999;40:2268-2274.
50. Taylor A, Namba K: In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (α-MSH). Immunol Cell Biol 2001;79:358-367.
51. Ferguson TA, Herndon JM, DuAe P: The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 1994;35:2643-2651.factor-